Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
PharmacoEconomics
Published in: PharmacoEconomics 15/2003

01-10-2003 | Original Research Article

Frequency of hospitalisations and inpatient care costs of manic episodes

In patients with bipolar I disorder in France

Authors: Dr Marie de Zelicourt, Roland Dardennes, Hélène Verdoux, Gian Gandhi, Babak Khoshnood, Eric Chomette, Marie-Laure Papatheodorou, Eric T. Edgell, Christian Even, Francis Fagnani

Published in: PharmacoEconomics | Issue 15/2003

Login to get access

Abstract

Background: Bipolar disorder is a chronic illness that may involve multiple relapses and result in substantial psychosocial impairment. However, very few recent studies have investigated the economic burden of the disease.
Objective: To assess the frequency of hospitalisation and the inpatient care costs associated with manic episodes in patients with bipolar I disorder in France.
Method: A cost-of-illness study was conducted based on available data using a hospital payer perspective. The lifetime prevalence of manic episodes was estimated from published epidemiological data using a random-effects meta-analysis. Data were obtained by a computerised literature search using the main scientific and medical databases. Additional epidemiological references were identified from published studies and textbooks. Data on frequency of hospitalisation and length of stay were collected from a large psychiatric university hospital. Data on unit costs for inpatient care were obtained from the accounting system of the largest hospital group in Paris, France for the year 1999.
Results: Extrapolating from international data on the average prevalence of bipolar I disorder, the proportion of rapid cycling patients and the average cycle duration, we estimated the annual number of manic episodes in patients with bipolar I disorder to be around 265 000 in France. Based on hospital data in Paris, the proportion of manic episodes that require hospitalisation was estimated to be around 63%. The average length of stay was 32.4 days and the hospitalisation-related costs were estimated to be around 8.8 billion French francs (€1.3 billion) [1999 values].
Conclusion: Our study highlights the lack of medical and economic data on the frequency and hospitalisation-related costs of manic episodes in patients with bipolar I disorder in France. As the lifetime prevalence of bipolar I disorder may be as high as 3% among adults, further studies are required in order to provide representative national data and to allow economic evaluations of costs related to bipolar I disorder in France.
Appendix
Available only for authorised users
Literature
1.
American Psychiatric Association. DSM-IV. Manuel diagnostique et statistique des troubles mentaux. Paris: Eds Masson, 1996: 1008
2.
Weissman MM, Myers JK. Affective disorders in a US urban community: the use of research diagnostic criteria in an epidemiological survey. Arch Gen Psychiatry 1978; 35 (11): 1304–11PubMedCrossRef
3.
Angst J. Epidémiologie des troubles bipolaires. In: Bourgeois ML, Verdoux H, editors. Les troubles bipolaires de l’humeur. Paris: Masson, 1995: 29–42
4.
Szadoczky E, Papp Z, Vitrai J, et al. The prevalence of major depressive and bipolar disorders in Hungary: results from a national epidemiologic survey. J Affect Disord 1998; 50 (2-3): 153–62CrossRef
5.
Faravelli C, Guerrini Degl’Innocenti B, Aiazzi L, et al. Epidemiology of mood disorders: a community survey in Florence. J Affect Disord 1990; 20 (2): 135–41CrossRef
6.
Robins LN, Regier DA. Psychiatric disorders in America: the Epidemiologic Catchment Area Study. New York: The Free Press, 1991
7.
Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Co-morbidity Survey. Arch Gen Psychiatry 1994; 51: 8–19PubMedCrossRef
8.
Lee CK, Kwak YS, Yamamoto J, et al. Psychiatric epidemiology in Korea: Part I: gender and age differences in Seoul. J Nerv Ment Dis 1990; 178 (4): 242–6PubMedCrossRef
9.
Chen CN, Wong J, Lee N, et al. The Shatin community mental Health survey in Hong Kong: II. major findings. Arch Gen Psychiatry 1993; 50: 125–33PubMedCrossRef
10.
Hwu HG, Yeh EK, Chang LY. Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule. Acta Psychiatr Scand 1989; 79: 136–47PubMedCrossRef
11.
Wittchen HU, Essau CA, Von Zerssen D, et al. Lifetime and six-month prevalence of mental disorders in the Munich follow-up study. Fur Arch Psychiatry Clin Neurosci 1992; 241: 247–58CrossRef
12.
Parsons PL. Mental health of Swansea’s old folk. Br J Prev Soc Med 1965; 19: 43–7PubMed
13.
Stefansson JG, Lindal E, Björnsson JK, et al. Lifetime prevalence of specific mental disorders among people born in Iceland in 1931. Acta Psychiatr Scand 1991; 84: 142–9PubMedCrossRef
14.
Bland RC, Orn H, Newman SC. Lifetime prevalence of psychiatric disorders in Edmonton. Acta Psychiatr Scand 1988; 77 Suppl. 338: 24–32CrossRef
15.
Wells JE, Bushnell JA, Homblow AR, et al. Christchurch Psychiatric Epidemiologic Study: I. methodology and lifetime prevalence for specific psychiatric disorders. Aust N Z J Psychiatry 1989; 23: 315–26PubMedCrossRef
16.
Canino GJ, Bird HR, Shrout PE, et al. The prevalence of specific psychiatric disorders in Puerto Rico. Arch Gen Psychiatry 1987; 44: 727–35PubMedCrossRef
17.
Suppes T, Dennehy EB, Gibbons EW. The longitudinal course of bipolar disorder. J Clin Psychiatry 2000; 61 Suppl. 9: 23–30PubMed
18.
Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press, 1990
19.
Fukuda K, Etch T, Iwadate T, et al. The course and prognosis of manic-depressive psychosis: a quantitative analysis of episodes and intervals. Tokohu J Exp Med 1983; 139: 299–307CrossRef
20.
Winokur G, Coryell W, Keller M, et al. A prospective followup of patients with bipolar and primary unipolar affective disorder. Arch Gen Psychiatry 1993; 50: 457–65PubMedCrossRef
21.
Perugi G, Akiskal HS, Rossi L, et al. Chronic mania: family history, prior course, clinical picture and social consequences. Br J Psychiatry 1997; 173: 514–8CrossRef
22.
Goldberg IF, Harrow M, Grossman LS. Course and outcome in bipolar affective disorder: a longitudinal follow-up study. Am J Psychiatry 1995; 152: 379–84PubMed
23.
Harris EC, Barraclough B. Suicide as an outcome for mental disorders. Br J Psychiatry 1997; 170: 205–28PubMedCrossRef
24.
Wyatt RJ, Henter I. An economic evaluation of manic-depressive illness - 1991. Soc Psychiatry Psychiatr Epidemiol 1995; 30: 213–9PubMed
25.
Begley CE, Annegers IF, Swann AC, et al. The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. Pharmacoeconomics 2001; 19 (5): 483–95PubMedCrossRef
26.
Simon GE, Unutzer J. Health care utilization and costs among patients treated for bipolar disorder in an insured population. Psychiatr Serv 1999; 50 (10): 1303–8PubMed
27.
Greenberg PE, Stilin LE, Frankelstein SN. The economic burden of depression in 1990. J Clin Psychiatry 1993; 54: 405–18PubMed
28.
Rouillon F, Limosin F. Coût de la prise en charge thérapeutique du trouble schizophrénique. In: Scotto JC, Bougerol T, editors. Les schizophrénies, aspects actuels. Niort: Médecine-Sciences, Flammarion, 1997: 255–60
29.
Laird NM, Mosteller F. Statistical methods for combining experimental results. Int J Technol Assess Health Care 1990; 6: 5–30PubMedCrossRef
30.
Organisation Mondiale de la Santé. Classification Statistique Internationale des Maladies et des problèmes de santé connexes. Dixième révision, vol 1; eds. Genève: OMS, 1993: 1335
31.
Direction des Finances, département du contrôle de gestion de l’AP-HP, comptabilité analytique de l’année 1999; Eds. Paris: Assistance Publique-Hôpitaux de Paris, 2000 Sep
32.
Brunetti PM. A prevalence survey of mental disorders in a rural commune in Vaucluse: methodological considerations. Acta Psychiatr Scand 1964; 40 (3): 323–58PubMedCrossRef
33.
Lepine JP, Lellouch J, Lovell A, et al. Anxiety and depressive disorders in a French population: methodology and preliminary results. Psychiatr Psychobiol 1989; 4: 267–74
34.
Kovess V, Gysens S, Chanoit PF. Une enquête de santé mentale: l’enquête de santé des Franciliens. Ann Med Psychol 1993; 151: 624–8
35.
Kovess V, Gysens S, Poinsard R, et al. La psychiatrie face aux problèmes sociaux: la prise en charge des RMIstes santà Paris. L’information Psychiatrique 1995; 3: 273–85
36.
Sadoun R, Quemada N, Chevalier A. Une approche épidémiologique des psychoses. L’encéphale 1979; 5: 99–113PubMed
37.
Boisguerin B, Parayre C, Quemada N. Enquête nationale sur la population prise en charge par les secteurs de psychiatrie générale. Données du 16 an 29 mars 1993; Eds. Paris: Minis tere du Travail et des Affaires sociales, Direction Générale de la Santé et de l’INSERM-CCOMS, 1994 Jul 1994
38.
Kessler RC, Rubinow DR, Holmes C, et al. The epidemiology of DSM-III-R bipolar disorder in a general population survey. Psychol Med 1997; 27: 1079–89PubMedCrossRef
39.
Bijl RV, Ravelli A, van Zessen G. Prevalence of psychiatric disorder in general population: results of the Netherlands Mental Health Survey and incidence study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 1998; 33: 587–95PubMedCrossRef
40.
Robins LN, Helzer JE, Croughan J, et al. National Institute of Mental Health diagnostic interview schedule: its history, char-acteristics, and validity. Arch Gen Psychiatry 1989; 38: 381–9CrossRef
41.
INSEE. Annuaire statistique de la France. Résultats de 1998, vol. 103, No. 45; eds. Paris: INSEE, 2000
42.
Fogarty F, Russell JM, Newman SC, et al. Epidemiology of psychiatric disorders in Edmonton. Mania. Acta Psychiatr Scand 1994; Suppl. 376: 16–23CrossRef
43.
Winokur G, Coryell W, Akiskal HS, et al. Manic-depressive (bipolar) disorder: the course in light of a prospective ten-year follow-up of 131 patients. Acta Psychiatr Scand 1994; 89: 102–10PubMedCrossRef
44.
45.
Roy-Byrne P, Post RM, Uhde TW, et al. The longitudinal course of récurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand 1985; 71 Suppl. 317: 1–34CrossRef
46.
Keller MB, Lavori PW, Coryell W, et al. Bipolar I: a five-year prospective follow-up. J Nerv Ment Dis 1993; 181: 238–45PubMedCrossRef
47.
Zis AP, Grof P, Webster M, et al. Prediction of relapse in recurrent affective disorder. Psychopharmacol Bull 1980; 16 (1): 47–9PubMed
48.
Tohen M, Waternaux CM, Tsuang MT, et al. Four-year followup of twenty-four first-episode manic patients. J Affect Disord 1990; 19: 79–86PubMedCrossRef
49.
Tondo L, Baldessarini RJ. Rapid cycling in women and men with bipolar manic-depressive disorders. Am J Psychiatry 1998; 155: 1434–6PubMed
50.
Dunner DL, Vijayalakshmy P, Fieve RR. Rapid cycling manic depressive patients. Compr Psychiatry 1977; 18 (6: 561–66CrossRef
51.
Kukopulos A, Reginaldi D, Floris G, et al. Course of the manic-depressive cycle and changes caused by treatments. Pharmakopsychiatrie Neuropsychopharmakologie 1980; 13 (4): 156–67
52.
Numberger J, Guroff JJ, Hamovit J, et al. A family study of rapid-cycling bipolar illness. J Affect Disord 1988; 15 (1): 87–91CrossRef
53.
Coryell W, Endicott J, Keller M. Rapidly cycling affective disorder. Demographics, diagnosis, family history, and course. Arch Gen Psychiatry 1992; 49 (2): 126–31PubMedCrossRef
54.
Maj M, Magliano L, Pirozzi R, et al. Validity of rapid cycling as a course specifier for bipolar disorder. Am J Psychiatry 1994; 151 (7): 1015–9PubMed
55.
56.
Escobar JI, Anthony JC, Canino G, et al. Use of neuroleptics, antidepressants, and lithium by U.S. community populations. Psychopharmacol Bull 1987; 23: 196–200PubMed
57.
Kehoe RF, Mander AJ. Lithium treatment: prescribing and monitoring habits in hospital and general practice. BMJ 1992; 304: 552–4PubMedCrossRef
Metadata
Title
Frequency of hospitalisations and inpatient care costs of manic episodes
In patients with bipolar I disorder in France
Authors
Dr Marie de Zelicourt
Roland Dardennes
Hélène Verdoux
Gian Gandhi
Babak Khoshnood
Eric Chomette
Marie-Laure Papatheodorou
Eric T. Edgell
Christian Even
Francis Fagnani
Publication date
01-10-2003
Publisher
Springer International Publishing
Published in
PharmacoEconomics / Issue 15/2003
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200321150-00002

Other articles of this Issue 15/2003

PharmacoEconomics 15/2003 Go to the issue

Original Research Article

Indirect costs in ambulatory patients with HIV/AIDS in Spain

Original Research Article

Methods to analyse cost data of patients who withdraw in a clinical trial setting

Original Research Article

Reductions in individual work productivity associated with type 2 diabetes mellitus

Original Research Article

Evaluating minimal clinically important differences for the acne-specific quality of life questionnaire

Original Research Article

Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden